Concepedia

Leyre Zubiri

LZ

55

Publications

5.9K

Citations

35

H-Index

2013

Active since

Affiliations

Massachusetts General Hospital(Current)

Harvard University

Dana-Farber Cancer Institute

Brigham and Women's Hospital

Vanderbilt University Medical Center

Leyre Zubiri is an author at Massachusetts General Hospital specializing in medicine, immunology, and immunotherapy.

ORCID

Top concepts

Publications per year

2013–2024

55

Publications

55

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

Nicole M. Kuderer, Toni K. Choueiri, Dimpy P. Shah et al. · The Lancet · 2020 · 1.8K citations · Full text

, , +11

Association Between Immune Checkpoint Inhibitors With Cardiovascular Events and Atherosclerotic Plaque

Zsófia D. Drobni, Raza M. Alvi, Jana Taron et al. · Circulation · 2020 · 507 citations · Full text

Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium

Petros Grivas, Ali Raza Khaki, Trisha M. Wise‐Draper et al. · Annals of Oncology · 2021 · 321 citations · Full text

The Incidence, Causes, and Risk Factors of Acute Kidney Injury in Patients Receiving Immune Checkpoint Inhibitors

Harish Seethapathy, Sophia Zhao, Donald F. Chute et al. · Clinical Journal of the American Society of Nephrology · 2019 · 291 citations · Full text

Quantitative Cell-Free Circulating BRAFV600E Mutation Analysis by Use of Droplet Digital PCR in the Follow-up of Patients with Melanoma Being Treated with BRAF Inhibitors

Miguel F. Sanmamed, Sara Fernández-Landázuri, Carmen Rodríguez et al. · Clinical Chemistry · 2014 · 236 citations · Full text

Rows per page

1–5 of 55